Amylyx Pharmaceuticals, Inc. - Common Stock — Cash Flow (NASDAQ:AMLX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends Documents

Quarterly Annual

Cash from operating activities -179.87 M11.92 M-167.65 M-123.34 M -126.58 M Cash from investing activities -238.99 M92.05 M75.65 M14.04 M -78.83 M Cash from financing activities 431.79 M3.54 M348 K257.03 M 196.09 M Free cash flow -179.87 M11.92 M-167.65 M-123.34 M -126.58 M

News

Stock Market Rally Buckles; Moderna, Gold, Bitcoin Surge While Walmart Tumbles: Weekly Review

Costco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead. - TipRanks.com

AMLX Rises as Avexitide Nears 2026-End Filing With Phase III Study Win

Profusa, Baidu, Amylyx Pharmaceuticals, FreeCast and Klarna Group: Why These 5 Stocks Are on Investors' R

Stocks Finish Lower as Chipmakers and AI Stocks Fall

AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial

Amylyx: Upgraded To Strong Buy On LUCIDITY Outcome, Avexitide, And 2026 Catalysts (AMLX)

Amylyx Pharmaceuticals, Inc. (AMLX) Discusses Positive Phase III LUCIDITY Topline Results for Avexitide in Post-Bariatric Hypoglycemia - Slideshow (NASDAQ:AMLX) 2026-08-18

Crude Oil Gains 1%; US Pending Home Sales Fall In July - Amylyx Pharmaceuticals (NASDAQ:AMLX), Fabrinet (

Chipmaker Sell-Off Weighs on Stock Indices

Stocks Retreat as Global Bond Yields Rise

Amylyx Pharmaceuticals Comes Closer to Potentially Delivering First Treatment for Weight Loss Surgery-Rel